Winter is coming, but MACRA is here: Reimbursement for quality and the shift to population-based care

2017 AUPN Fall Chairs Session
(Held in conjunction with ANA Annual Meeting)

The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) ended the Sustainable Growth Rate formula, which threatened massive reductions in Medicare payments, and replaced it with a program that bases reimbursements on quality and innovation.  How will this change affect academic Neurology departments? What are the implications of MACRA for academic neurology? How can we address the new MACRA requirements using either Advanced Alternative Payment Models (APMs) or the Merit-based Incentive Payment System (MIPS)? More broadly, how will population health measures including disease prediction, prevention, and early intervention, be incorporated into academic neurology practice?  Can such practices improve outcomes and reduce costs, and will they be adequately reimbursed

Learning Objectives:
By the end of this session, you should be able to return to your institutions and:

1. Explain MACRA’s two major pathways: the Merit-based Incentive Payment System (MIPS) and Advanced Alternative Payment Models (AAPMs)
2, Implement a plan to report under MIPS or participate in AAPMs
3. Develop strategies to manage the impact of value based care on academic neurology practices

Marc Nuwer, MD, PhD; University of California, Los Angeles, Reed Neurological Research Center
Lyell Jones MD; Mayo Clinic Rochester
Presentation Slides

Roseville, MN 55113 | Roseville, MN 55113 | 952-545-6724 |
© 2023 Association of University Professors of Neurology. All rights reserved. Articles of Incorporation | Terms of Use

Reset password